Allergan suing FDA over off-label policy
Published:
NEW YORK (AP) -- Allergan Inc., the maker of the Botox wrinkle treatment, challenged the government's ban on off-label drug marketing to doctors, saying it violates the company's right to freedom of speech.
sign out Welcome,
(edit)